Bibliography
Adams, B., H. Bak and A. D. Tustian (2020). ”Moving from the bench towards a large scale, industrial platform process for adeno-associated viral vector purification.”117 (10): 3199-3211.
Arnold, L., K. Lee, J. Rucker-Pezzini and J. H. Lee (2019). ”Implementation of Fully Integrated Continuous Antibody Processing: Effects on Productivity and COGm.” 14 (2): 1800061.
Asper, M., T. Hanrieder, A. Quellmalz and A. Mihranyan (2015). ”Removal of xenotropic murine leukemia virus by nanocellulose based filter paper.” Biologicals 43 (6): 452-456.
Barone, P. W., M. E. Wiebe, J. C. Leung, I. T. M. Hussein, F. J. Keumurian, J. Bouressa, A. Brussel, D. Chen, M. Chong, H. Dehghani, L. Gerentes, J. Gilbert, D. Gold, R. Kiss, T. R. Kreil, R. Labatut, Y. Li, J. Müllberg, L. Mallet, C. Menzel, M. Moody, S. Monpoeho, M. Murphy, M. Plavsic, N. J. Roth, D. Roush, M. Ruffing, R. Schicho, R. Snyder, D. Stark, C. Zhang, J. Wolfrum, A. J. Sinskey and S. L. Springs (2020). ”Viral contamination in biologic manufacture and implications for emerging therapies.” Nature Biotechnology 38 (5): 563-572.
Bartels, J., A. G. Batista, S. Kroll, M. Maas and K. Rezwan (2019). ”Hydrophobic ceramic capillary membranes for versatile virus filtration.” Journal of Membrane Science570-571 : 85-92.
Bolton, G., M. Cabatingan, M. Rubino, S. Lute, K. Brorson and M. Bailey (2005). ”Normal‐flow virus filtration: detection and assessment of the endpoint in bioprocessing.”Biotechnology and applied biochemistry 42 (2): 133-142.
Bolton, G., J. Cormier, M. Krishnan, J. Lewnard and H. Lutz (2006). ”Integrity testing of normal flow parvovirus filters using air-liquid based tests.” Bioprocessing Journal 5 (1): 50.
Bolton, G. R., S. Spector and D. LaCasse (2006). ”Increasing the capacity of parvovirus‐retentive membranes: performance of the Viresolve™ Prefilter.” Biotechnology and applied biochemistry 43 (1): 55-63.
Brorson, K., S. Krejci, K. Lee, E. Hamilton, K. Stein and Y. Xu (2003). ”Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinant proteins.” 82 (3): 321-329.
Brorson, K., G. Miesegaes, O. Tounekti, J. Skene and J. Blumel (2014). ”Conference Summary: Gaps, Lessons Learned, and Areas for Improvement.” PDA Journal of Pharmaceutical Science and Technology 68 (1): 83-89.
Brown, A., C. Bechtel, J. Bill, H. Liu, J. Liu, D. McDonald, S. Pai, A. Radhamohan, R. Renslow, B. Thayer, S. Yohe and C. Dowd (2010). ”Increasing parvovirus filter throughput of monoclonal antibodies using ion exchange membrane adsorptive pre-filtration.” 106 (4): 627-637.
Brown, M. R., M. S. Burnham, S. A. Johnson, S. C. Lute, K. A. Brorson and D. J. Roush (2018). ”Evaluating the effect of in-process material on the binding mechanisms of surrogate viral particles to a multi-modal anion exchange resin.” J Biotechnol 267 : 29-35.
Brown, M. R., M. S. Burnham, S. C. Lute, S. A. Johnson, A. A. Walsh, K. A. Brorson and D. J. Roush (2018). ”Defining the mechanistic binding of viral particles to a multi-modal anion exchange resin.” Biotechnol Prog 34 (4): 1019-1026.
Brown, M. R., S. A. Johnson, K. A. Brorson, S. C. Lute and D. J. Roush (2017). ”A step-wise approach to define binding mechanisms of surrogate viral particles to multi-modal anion exchange resin in a single solute system.” 114 (7): 1487-1494.
Carbrello, C., J. Perreault, D. Nhiem, T. Greenhalgh, M. Priest, A. Leahy, D. DeCesaro, N. Nyugen, K. Mann, M. McGlothlen, J. Broe, J. Orlando, K. Cunningham, Y. Zeng and K. Rautio (2017). ”Upstream Virus Safety: Protect Your Bioreactor By Media Filtration.” MilliporeSigma, Bedford MA USA .
Chen, D. (2014). ”Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Virus-Retentive Filtration.” 68 (1): 38-50.
Chen, Q. and D. Chen (2015). ”Viral clearance of traditional unit operations: virus-retentive filtration.”PDA J Pharm Sci Technol 69 (1): 142-153.
David, L., B. Maiser, M. Lobedann, P. Schwan, M. Lasse, H. Ruppach and G. Schembecker (2019). ”Virus study for continuous low pH viral inactivation inside a coiled flow inverter.”116 (4): 857-869.
De Vilmorin, P., A. Slocum, T. Jaber, O. Schaefer, H. Ruppach and P. Genest (2015). ”Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpike<sup>TM</sup> Viruses.” 69 (3): 440-449.
DiLeo, A. J., A. E. Allegrezza and S. E. Builder (1992). ”High Resolution Removal of Virus from Protein Solutions Using a Membrane of Unique Structure.” Bio/Technology10 (2): 182-188.
Dishari, S. K., M. R. Micklin, K. J. Sung, A. L. Zydney, A. Venkiteshwaran and J. N. Earley (2015). ”Effects of solution conditions on virus retention by the Viresolve® NFP filter.”Biotechnol Prog 31 (5): 1280-1286.
EMEA (1996). ”Note for Guidance on Virus Validation Studies: The Design, Contriubtion and Interpretation of Studies Validating the Inactivation and Removal of Viruses.”CMPM/BWP/268/95 .
Fallahianbijan, F., S. Giglia, C. Carbrello and A. L. Zydney (2017). ”Use of fluorescently-labeled nanoparticles to study pore morphology and virus capture in virus filtration membranes.” Journal of Membrane Science 536 : 52-58.
Fan, R., F. Namila, D. Sansongko, S. R. Wickramasinghe, M. Jin, D. Kanani and X. Qian ”The effects of flux on the clearance of minute virus of mice during constant flux virus filtration.” n/a (n/a).
Gefroh, E., H. Dehghani, M. McClure, L. Connell-Crowley and G. Vedantham (2014). ”Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.” PDA J Pharm Sci Technol 68 (3): 297-311.
Gefroh, E., A. Hewig, G. Vedantham, M. McClure, A. Krivosheyeva, A. Lajmi and Y. Lu (2013). ”Multipronged approach to managing beta-glucan contaminants in the downstream process: Control of raw materials and filtration with charge-modified nylon 6,6 membrane filters.” 29 (3): 672-680.
Giglia, S., J. Caulmare, D. Nhiem and D. Porreca (2016). ”Air-water binary gas integrity test for sterilizing and virus filters.” pdajpst.2016.006437.
Gustafsson, O., S. Gustafsson, L. Manukyan and A. Mihranyan (2018). ”Significance of Brownian Motion for Nanoparticle and Virus Capture in Nanocellulose-Based Filter Paper.”8 (4): 90.
Gustafsson, S., P. Lordat, T. Hanrieder, M. Asper, O. Schaefer and A. Mihranyan (2016). ”Mille-feuille paper: a novel type of filter architecture for advanced virus separation applications.” Materials Horizons 3 (4): 320-327.
Gustafsson, S. and A. Mihranyan (2016). ”Strategies for Tailoring the Pore-Size Distribution of Virus Retention Filter Papers.” ACS Applied Materials & Interfaces8 (22): 13759-13767.
Gustafsson, S. and A. Mihranyan (2017). ”Investigating Protein Throughput, Vmax Values and Virus Removal Efficiency of the Paper Based Mille-Feuille Filter.” 253rd National Meeting of the American-Chemical-Society (ACS) on Advanced Materials, Technologies, Systems, and Processes, San Francisco, CA, April 02-06, 2017 253 .
Holstein, M., D. Jang, C. Urrea, L. S. Botta, W. Grimm, S. Ghose and Z. J. Li (2021). ”Control of leached beta-glucan levels from depth filters by an improved depth filtration flush strategy.” 37 (1): e3086.
Hongo-Hirasaki, T., M. Komuro and S. Ide (2010). ”Effect of antibody solution conditions on filter performance for virus removal filter Planova™ 20N.” 26 (4): 1080-1087.
ICH (1998). ”International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability–FDA. Notice.” Fed Regist 63 (185): 51074-51084.
Johnson, S. A., M. R. Brown, S. C. Lute and K. A. Brorson (2017). ”Adapting viral safety assurance strategies to continuous processing of biological products.”114 (1): 21-32.
Johnson, S. A. and D. Roush (2018). ”Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing.” 72 (5): 516-524.
Junter, G.-A. and L. Lebrun (2017). ”Cellulose-based virus-retentive filters: a review.” Reviews in Environmental Science and Bio/Technology 16 (3): 455-489.
Khan, N. Z., J. J. Parrella, P. W. Genest and M. S. Colman (2009). ”Filter preconditioning enables representative scaled-down modelling of filter capacity and viral clearance by mitigating the impact of virus spike impurities.”Biotechnol Appl Biochem 52 (Pt 4): 293-301.
Khanal, O., N. Singh, S. J. Traylor, X. Xu, S. Ghose, Z. J. Li and A. M. Lenhoff (2018). ”Contributions of depth filter components to protein adsorption in bioprocessing.”115 (8): 1938-1948.
Kleindienst, B. and A. Manzke (2016). ”Virus Risk Mitigation in Cell Culture Media.” BioPharm International 29 (10)
Kreil, T. R. and D. Roush (2018). ”Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations—Virus Filtration/Inactivation.” PDA Journal of Pharmaceutical Science and Technology 72 (5): 470-478.
LaCasse, D., S. Lute, M. Fiadeiro, J. Basha, M. Stork, K. Brorson, R. Godavarti and C. Gallo (2016). ”Mechanistic failure mode investigation and resolution of parvovirus retentive filters.” Biotechnol Prog 32 (4): 959-970.
Lefkowitz, E. J., D. M. Dempsey, R. C. Hendrickson, R. J. Orton, S. G. Siddell and D. B. Smith (2017). ”Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV).” Nucleic Acids Research 46 (D1): D708-D717.
Liu, S., M. Carroll, R. Iverson, C. Valera, J. Vennari, K. Turco, R. Piper, R. Kiss and H. Lutz (2000). ”Development and Qualification of a Novel Virus Removal Filter for Cell Culture Applications.” Biotechnology Progress 16 (3): 425-434.
Lubiniecki, A. S. (2011). ”Evolution of Approaches to Viral Safety Issues for Biological Products.”65 (6): 547-556.
Lute, S. (2015). An Update of the FDA Viral Clearance Database to include Regulatory Submission until 2014.PDA Europe Virus & TSE Safety Forum . Lisbon, Portugal.
Lute, S., M. Bailey, J. Combs, M. Sukumar and K. Brorson (2007). ”Phage passage after extended processing in small-virus-retentive filters.” Biotechnol Appl Biochem47 (Pt 3): 141-151.
Lute, S., K. Brorson, M. Cabatingan, T. Saravara, G. Bolton, D. LaCasse, J. Carter, M. Sukomar, J. Combs and M. Bailey (2005). Enterobacteriophage Phi X174 clearance versus flow decay in NFP virus filters . ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC 1155 16TH ST, NW, WASHINGTON, DC 20036 USA.
Lute, S., J. Kozaili, S. Johnson, K. Kobayashi and D. Strauss (2020). ”Development of small-scale models to understand the impact of continuous downstream bioprocessing on integrated virus filtration.” 36 (3): e2962.
Lute, S., W. Riordan, L. F. Pease, D.-H. Tsai, R. Levy, M. Haque, J. Martin, I. Moroe, T. Sato, M. Morgan, M. Krishnan, J. Campbell, P. Genest, S. Dolan, K. Tarrach, A. Meyer, M. R. Zachariah, M. J. Tarlov, M. Etzel and K. Brorson (2008). ”A Consensus Rating Method for Small Virus-Retentive Filters. I. Method Development.”62 (5): 318-333.
Lutz, H., W. Chang, T. Blandl, G. Ramsey, J. Parella, J. Fisher and E. Gefroh (2011). ”Qualification of a novel inline spiking method for virus filter validation.”27 (1): 121-128.
Manukyan, L., P. Li, S. Gustafsson and A. Mihranyan (2019). ”Growth media filtration using nanocellulose-based virus removal filter for upstream biopharmaceutical processing.” Journal of Membrane Science 572 : 464-474.
Manukyan, L., J. Padova and A. Mihranyan (2019). ”Virus removal filtration of chemically defined Chinese Hamster Ovary cells medium with nanocellulose-based size exclusion filter.” Biologicals 59 : 62-67.
Marques, B. F., D. J. Roush and K. E. Göklen (2009). ”Virus filtration of high-concentration monoclonal antibody solutions.” Biotechnol Prog 25 (2): 483-491.
Mattila, J., M. Clark, S. Liu, J. Pieracci, T. R. Gervais, E. Wilson, O. Galperina, X. Li, D. Roush, K. Zoeller, H. Brough and C. Simpson-Platre (2016). ”Retrospective Evaluation of Low-pH Viral Inactivation and Viral Filtration Data from a Multiple Company Collaboration.” PDA J Pharm Sci Technol70 (3): 293-299.
MerckMillipore (2017). ”Viresolve®Barrier Filters.” Lit No. DS1401EN00 Ver. 1.0 2016-00378 12/2017 .
Metreveli, G., L. Wågberg, E. Emmoth, S. Belák, M. Strømme and A. Mihranyan (2014). ”A Size-Exclusion Nanocellulose Filter Paper for Virus Removal.” 3 (10): 1546-1550.
Miesegaes, G., S. Lute and K. Brorson (2010). ”Analysis of viral clearance unit operations for monoclonal antibodies.” Biotechnology and Bioengineering 106 (2): 238-246.
Nguyen, H. C., A. L. Langland, J. P. Amara, M. Dullen, D. S. Kahn and J. A. Costanzo (2019). ”Improved HCP Reduction Using a New, All-Synthetic Depth Filtration Media Within an Antibody Purification Process.” 14 (1): 1700771.
Nowak, T., B. Popp and N. J. Roth (2019). ”Choice of parvovirus model for validation studies influences the interpretation of the effectiveness of a virus filtration step.”Biologicals 60 : 85-92.
Oh, D. J., S. K. Choi and H. N. Chang (1994). ”High-density continuous cultures of hybridoma cells in a depth filter perfusion system.” 44 (8): 895-901.
Patt, E., W. Dong and W. Gang (2015). ”Continuous Bioprocessing: Part I, Final Report.” Project MIT-FDA-15F04 .
PDA (2008). Technical Report No. 41 Virus Filtration .
PDA (2010). ”Technical Report No. 47 Preparation of Virus Spikes Used for Virus Clearance Studies.”
PDA (2021). PDA Standard 04-2021: Phage Retention Nomenclature Rating for Small- and Large-Virus Retentive Filters .
Phillips, M. W., G. Bolton, M. Krishnan, J. J. Lewnard and B. Raghunath (2007). 11 Virus Filtration Process Design and Implementation. Process Scale Bioseparations for the Biopharmaceutical Industry : 333.
Riordan, W., K. Brorson, S. Lute and M. Etzel (2009). ”Examination of the Adsorption of Large Biological Molecules to Anion Exchange Surfaces Using Surface Plasmon Resonance.”Separation Science and Technology 45 (1): 1-10.
Roth, N. J., H. O. Dichtelmüller, F. Fabbrizzi, E. Flechsig, A. Gröner, M. Gustafson, J. I. Jorquera, T. R. Kreil, D. Misztela, E. Moretti, M. Moscardini, G. Poelsler, J. More, P. Roberts, A. Wieser and R. Gajardo ”Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers.” n/a (n/a).
Roth, N. J., H. O. Dichtelmüller, F. Fabbrizzi, E. Flechsig, A. Gröner, M. Gustafson, J. I. Jorquera, T. R. Kreil, D. Misztela, E. Moretti, M. Moscardini, G. Poelsler, J. More, P. Roberts, A. Wieser and R. Gajardo (2020). ”Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 yearsʼ experience of the plasma protein manufacturers.”60 (11): 2661-2674.
Roush, D. and J. Ma (2016). ”Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration.” PDA J Pharm Sci Technol70 (5): 417-427.
Shethji, J. K., R. M. Dorin and S. Robbins (2019). Isoporous self-assembled block copolymer films containing high molecular weight hydrophilic additives and methods of making the same.
Singh, N., A. Arunkumar, M. Peck, A. M. Voloshin, A. M. Moreno, Z. Tan, J. Hester, M. C. Borys and Z. J. Li (2017). ”Development of adsorptive hybrid filters to enable two-step purification of biologics.” MAbs 9 (2): 350-363.
Slocum, A., M. Burnham, P. Genest, A. Venkiteshwaran, D. Chen and J. Hughes (2013). ”Impact of virus preparation quality on parvovirus filter performance.” 110 (1): 229-239.
Soluk, L., H. Price, C. Sinclair, D. Atalla-Mikhail and M. Genereux (2008). ”Pathogen safety of intravenous Rh immunoglobulin liquid and other immune globulin products: enhanced nanofiltration and manufacturing process overview.” Am J Ther15 (5): 435-443.
Stanley, B., V. Holmes, R. Manzari, C. Romanowski, A. Tessarz, H. Ruppach and J. Schreffler (2021). ”Twenty Plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal.” PDA Journal of Pharmaceutical Science and Technology In Press .
Strauss, D., J. Goldstein, T. Hongo-Hirasaki, Y. Yokoyama, N. Hirotomi, T. Miyabayashi and D. Vacante (2017). ”Characterizing the impact of pressure on virus filtration processes and establishing design spaces to ensure effective parvovirus removal.” Biotechnol Prog 33 (5): 1294-1302.
Strauss, D. M., S. Lute, Z. Tebaykina, D. D. Frey, C. Ho, G. S. Blank, K. Brorson, Q. Chen and B. Yang (2009). ”Understanding the mechanism of virus removal by Q sepharose fast flow chromatography during the purification of CHO-cell derived biotherapeutics.” 104 (2): 371-380.
Stuckey, J., D. Strauss, A. Venkiteshwaran, J. Gao, W. Luo, M. Quertinmont, S. O’Donnell and D. Chen (2014). ”A novel approach to achieving modular retrovirus clearance for a parvovirus filter.” Biotechnol Prog 30 (1): 79-85.
Swalec, J. F., S. Feng and E. Patt (2015). ”Continuous Bioprocessing: Part II, Final Report.” Project MIT-FDA-15F04 .
Tang, A., I. Ramos, K. Newell and K. D. Stewart (2020). ”A novel high-throughput process development screening tool for virus filtration.” Journal of Membrane Science611 : 118330.
WHO (2004). ”Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products.” WHO Technical Report924 .
Wolfgang, M., A. Mitterer, M. Reiter, M. Hasslacher, L. Grillberger and T. R. Kreil (2013). Virus filtration of cell culture media.
Wu, H. and D. K. Schwartz (2020). ”Nanoparticle Tracking to Probe Transport in Porous Media.”Accounts of Chemical Research 53 (10): 2130-2139.
Zeytuncu, B., M. Ürper, İ. Koyuncu and V. V. Tarabara (2018). ”Photo-crosslinked PVA/PEI electrospun nanofiber membranes: Preparation and preliminary evaluation in virus clearance tests.” Separation and Purification Technology197 : 432-438.